{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:46:06Z","timestamp":1792579566043,"version":"4.5.0"},"reference-count":51,"publisher":"China Science Publishing & Media Ltd.","issue":"10","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2026,10,1]]},"DOI":"10.3724\/abbs.2025225","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T09:59:46Z","timestamp":1764842386000},"page":"2284-2301","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":3,"title":["Calycosin alleviates blood-brain barrier disruption after cerebral ischemia-reperfusion injury by inhibiting NLRP3-mediated pyroptosis"],"prefix":"10.3724","volume":"58","author":[{"given":"Qiguang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoya","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2026,1,4]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.2174\/1570159X21666230717144752","volume":"21","author":"Liu A","year":"2023","unstructured":"Liu A, Hu J, Yeh TS, Wang C, Tang J, Huang X, Chen B. Neuroprotective strategies for stroke by natural products: advances and perspectives. CN, 2023, 21: 2283-2309.","journal-title":"CN"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"1374445","DOI":"10.3389\/fphar.2024.1374445","volume":"15","author":"Zhang G","year":"2024","unstructured":"Zhang G, Wang Q, Jiang B, Yao L, Wu W, Zhang X, Wan D. Progress of medicinal plants and their active metabolites in ischemia-reperfusion injury of stroke: a novel therapeutic strategy based on regulation of crosstalk between mitophagy and ferroptosis. Front Pharmacol, 2024, 15:","journal-title":"Front Pharmacol"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"e14631","DOI":"10.1111\/cns.14631","volume":"30","author":"Jia M","year":"2024","unstructured":"Jia M, Jin F, Li S, Ren C, Ruchi M, Ding Y, Zhao W. No-reflow after stroke reperfusion therapy: an emerging phenomenon to be explored. CNS Neurosci Ther, 2024, 30:","journal-title":"CNS Neurosci Ther"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1161\/STROKEAHA.122.039337","volume":"54","author":"Zhou Y","year":"2023","unstructured":"Zhou Y, He Y, Yan S, Chen L, Zhang R, Xu J, Hu H. Reperfusion injury is associated with poor outcome in patients with recanalization after thrombectomy. Stroke, 2023, 54: 96-104.","journal-title":"Stroke"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neuroscience.2022.10.020","volume":"507","author":"Li M","year":"2022","unstructured":"Li M, Tang H, Li Z, Tang W. Emerging treatment strategies for cerebral ischemia-reperfusion injury. Neuroscience, 2022, 507: 112-124.","journal-title":"Neuroscience"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/med.21817","volume":"42","author":"Tuo QZ","year":"2022","unstructured":"Tuo QZ, Zhang ST, Lei P. Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications. Med Res Rev, 2022, 42: 259-305.","journal-title":"Med Res Rev"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41392-023-01688-x","volume":"9","author":"Zhang M","year":"2024","unstructured":"Zhang M, Liu Q, Meng H, Duan H, Liu X, Wu J, Gao F. Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets. Sig Transduct Target Ther, 2024, 9:","journal-title":"Sig Transduct Target Ther"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1021\/acschemneuro.3c00536","volume":"15","author":"Panbhare K","year":"2024","unstructured":"Panbhare K, Pandey R, Chauhan C, Sinha A, Shukla R, Kaundal RK. Role of NLRP3 inflammasome in stroke pathobiology: current therapeutic avenues and future perspective. ACS Chem Neurosci, 2024, 15: 31-55.","journal-title":"ACS Chem Neurosci"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"1151196","DOI":"10.3389\/fphar.2023.1151196","volume":"14","author":"Long JX","year":"2023","unstructured":"Long JX, Tian MZ, Chen XY, Yu HH, Ding H, Liu F, Du K. The role of NLRP3 inflammasome-mediated pyroptosis in ischemic stroke and the intervention of traditional Chinese medicine. Front Pharmacol, 2023, 14:","journal-title":"Front Pharmacol"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/ptr.6557","volume":"34","author":"Zhai J","year":"2020","unstructured":"Zhai J, Tao L, Zhang S, Gao H, Zhang Y, Sun J, Song Y. Calycosin ameliorates doxorubicin-induced cardiotoxicity by suppressing oxidative stress and inflammation via the sirtuin 1\u2013NOD-like receptor protein 3 pathway. Phytother Res, 2020, 34: 649-659.","journal-title":"Phytother Res"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"154924","DOI":"10.1016\/j.phymed.2023.154924","volume":"118","author":"Li Y","year":"2023","unstructured":"Li Y, Hu S, Chen Y, Zhang X, Gao H, Tian J, Chen J. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-\u03b1 splice variant ER-\u03b130-mediated PI3K\/AKT signaling pathway. Phytomedicine, 2023, 118:","journal-title":"Phytomedicine"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3390\/antiox11020222","volume":"11","author":"Chaouhan HS","year":"2022","unstructured":"Chaouhan HS, Li X, Sun KT, Wang IK, Yu TM, Yu SH, Chen KB. Calycosin alleviates paraquat-induced neurodegeneration by improving mitochondrial functions and regulating autophagy in a drosophila model of Parkinson\u2019s disease. Antioxidants, 2022, 11:","journal-title":"Antioxidants"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1159\/000487031","volume":"45","author":"Wang Y","year":"2018","unstructured":"Wang Y, Ren Q, Zhang X, Lu H, Chen J. Neuroprotective mechanisms of calycosin against focal cerebral ischemia and reperfusion injury in rats. Cell Physiol Biochem, 2018, 45: 537-546.","journal-title":"Cell Physiol Biochem"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3724\/abbs.2023125","volume":"55","author":"Li X","year":"2023","unstructured":"Li X, Yang X, Lu H, Wang W, Cai L, Chen J, Wang Y. Calycosin attenuates the inflammatory damage of microglia induced by oxygen and glucose deprivation through the HMGB1\/TLR4\/NF-\u03baB signaling pathway. Acta Biochim Biophys Sin, 2023, 55: 1415-1424.","journal-title":"Acta Biochim Biophys Sin"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1161\/01.STR.20.1.84","volume":"20","author":"Longa EZ","year":"1989","unstructured":"Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke, 1989, 20: 84-91.","journal-title":"Stroke"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"926","DOI":"10.3389\/fphar.2018.00926","volume":"9","author":"Lu D","year":"2018","unstructured":"Lu D, Mai HC, Liang YB, Xu BD, Xu AD, Zhang YS. Beneficial role of rosuvastatin in blood-brain barrier damage following experimental ischemic stroke. Front Pharmacol, 2018, 9:","journal-title":"Front Pharmacol"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"14438","DOI":"10.1038\/s41598-024-64815-w","volume":"14","author":"Zheng Z","year":"2024","unstructured":"Zheng Z, Zhu L, Qiu H, Zheng W, You P, Chen S, Hu C. Neferine inhibits BMECs pyroptosis and maintains blood-brain barrier integrity in ischemic stroke by triggering a cascade reaction of PGC-1\u03b1. Sci Rep, 2024, 14:","journal-title":"Sci Rep"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41420-023-01440-y","volume":"9","author":"Long J","year":"2023","unstructured":"Long J, Sun Y, Liu S, Yang S, Chen C, Zhang Z, Chu S. Targeting pyroptosis as a preventive and therapeutic approach for stroke. Cell Death Discov, 2023, 9:","journal-title":"Cell Death Discov"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"20417314241226551","DOI":"10.1177\/20417314241226551","volume":"15","author":"Qi L","year":"2024","unstructured":"Qi L, Wang F, Sun X, Li H, Zhang K, Li J. Recent advances in tissue repair of the blood-brain barrier after stroke. J Tissue Eng, 2024, 15:","journal-title":"J Tissue Eng"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13578-023-01126-z","volume":"13","author":"Gao H","year":"2023","unstructured":"Gao H, Chen H, Cui GY, Hu JX. Damage mechanism and therapy progress of the blood-brain barrier after ischemic stroke. Cell Biosci, 2023, 13:","journal-title":"Cell Biosci"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.bbi.2024.02.001","volume":"117","author":"Oladapo A","year":"2024","unstructured":"Oladapo A, Jackson T, Menolascino J, Periyasamy P. Role of pyroptosis in the pathogenesis of various neurological diseases. Brain Behav Immun, 2024, 117: 428-446.","journal-title":"Brain Behav Immun"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3892\/mmr.2024.13170","volume":"29","author":"Duan WL","year":"2024","unstructured":"Duan WL, Wang XJ, Ma YP, Sheng ZM, Dong H, Zhang LY, Zhang BG. Therapeutic strategies targeting the NLRP3\u2011mediated inflammatory response and pyroptosis in cerebral ischemia\/reperfusion injury (Review). Mol Med Rep, 2024, 29:","journal-title":"Mol Med Rep"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/biof.1991","volume":"50","author":"Zhang X","year":"2024","unstructured":"Zhang X, Yang Q, Zhang R, Zhang Y, Zeng W, Yu Q, Zeng M. Sodium Danshensu ameliorates cerebral ischemia\/reperfusion injury by inhibiting CLIC4\/NLRP3 inflammasome-mediated endothelial cell pyroptosis. BioFactors, 2024, 50: 74-88.","journal-title":"BioFactors"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12974-021-02137-8","volume":"18","author":"Xu Q","year":"2021","unstructured":"Xu Q, Zhao B, Ye Y, Li Y, Zhang Y, Xiong X, Gu L. Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke. J Neuroinflamm, 2021, 18:","journal-title":"J Neuroinflamm"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41388-023-02907-z","volume":"43","author":"Palma FR","year":"2024","unstructured":"Palma FR, Gantner BN, Sakiyama MJ, Kayzuka C, Shukla S, Lacchini R, Cunniff B. ROS production by mitochondria: function or dysfunction?. Oncogene, 2024, 43: 295-303.","journal-title":"Oncogene"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","volume":"18","author":"Huang Y","year":"2021","unstructured":"Huang Y, Xu W, Zhou R. NLRP3 inflammasome activation and cell death. Cell Mol Immunol, 2021, 18: 2114-2127.","journal-title":"Cell Mol Immunol"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1084\/jem.20172222","volume":"215","author":"Boucher D","year":"2018","unstructured":"Boucher D, Monteleone M, Coll RC, Chen KW, Ross CM, Teo JL, Gomez GA. Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activity. J Exp Med, 2018, 215: 827-840.","journal-title":"J Exp Med"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/cr.2015.139","volume":"25","author":"He W","year":"2015","unstructured":"He W, Wan H, Hu L, Chen P, Wang X, Huang Z, Yang ZH. Gasdermin D is an executor of pyroptosis and required for interleukin-1\u03b2 secretion. Cell Res, 2015, 25: 1285-1298.","journal-title":"Cell Res"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"5971","DOI":"10.1038\/s41598-018-24350-x","volume":"8","author":"Ismael S","year":"2018","unstructured":"Ismael S, Zhao L, Nasoohi S, Ishrat T. Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke. Sci Rep, 2018, 8:","journal-title":"Sci Rep"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.bbi.2020.12.009","volume":"92","author":"Franke M","year":"2021","unstructured":"Franke M, Bieber M, Kraft P, Weber ANR, Stoll G, Schuhmann MK. The NLRP3 inflammasome drives inflammation in ischemia\/reperfusion injury after transient middle cerebral artery occlusion in mice. Brain Behav Immun, 2021, 92: 221-231.","journal-title":"Brain Behav Immun"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.21037\/atm-21-5752","volume":"9","author":"Liu J","year":"2021","unstructured":"Liu J, Ma W, Zang CH, Wang GD, Zhang SJ, Wu HJ, Zhu KW. Salidroside inhibits NLRP3 inflammasome activation and apoptosis in microglia induced by cerebral ischemia\/reperfusion injury by inhibiting the TLR4\/NF-\u03baB signaling pathway. Ann Transl Med, 2021, 9:","journal-title":"Ann Transl Med"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"114197","DOI":"10.1016\/j.expneurol.2022.114197","volume":"357","author":"Xia P","year":"2022","unstructured":"Xia P, Marjan M, Liu Z, Zhou W, Zhang Q, Cheng C, Zhao M. Chrysophanol postconditioning attenuated cerebral ischemia-reperfusion injury induced NLRP3-related pyroptosis in a TRAF6-dependent manner. Exp Neurol, 2022, 357:","journal-title":"Exp Neurol"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"106547","DOI":"10.1016\/j.intimp.2020.106547","volume":"84","author":"Fu C","year":"2020","unstructured":"Fu C, Zhang X, Lu Y, Wang F, Xu Z, Liu S, Zheng H. Geniposide inhibits NLRP3 inflammasome activation via autophagy in BV-2 microglial cells exposed to oxygen\u2013glucose deprivation\/reoxygenation. Int Immunopharmacol, 2020, 84:","journal-title":"Int Immunopharmacol"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"113776","DOI":"10.1016\/j.jep.2021.113776","volume":"270","author":"Ma DC","year":"2021","unstructured":"Ma DC, Zhang NN, Zhang YN, Chen HS. Salvianolic Acids for Injection alleviates cerebral ischemia\/reperfusion injury by switching M1\/M2 phenotypes and inhibiting NLRP3 inflammasome\/pyroptosis axis in microglia in vivo and in vitro. J Ethnopharmacol, 2021, 270:","journal-title":"J Ethnopharmacol"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.2147\/DDDT.S257020","volume":"14","author":"Zheng HZ","year":"2020","unstructured":"Zheng HZ, Shen X, He YY, Yan XL, Wang SX, Yu AM, Wang LS. Pharmacokinetic analysis of huangqi guizhi wuwu decoction on blood and brain tissue in rats with normal and cerebral ischemia-reperfusion injury by microdialysis with HPLC-MS\/MS. Drug Des Devel Ther, 2020, 14: 2877-2888.","journal-title":"Drug Des Devel Ther"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"154432","DOI":"10.1016\/j.phymed.2022.154432","volume":"106","author":"Du Y","year":"2022","unstructured":"Du Y, Li C, Xu S, Yang J, Wan H, He Y. LC-MS\/MS combined with blood-brain dual channel microdialysis for simultaneous determination of active components of astragali radix-safflower combination and neurotransmitters in rats with cerebral ischemia reperfusion injury: application in pharmacokinetic and pharmacodynamic study. Phytomedicine, 2022, 106:","journal-title":"Phytomedicine"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/tox.23449","volume":"37","author":"Lu CY","year":"2022","unstructured":"Lu CY, Day CH, Kuo CH, Wang TF, Ho TJ, Lai PF, Chen RJ. Calycosin alleviates H2O2-induced astrocyte injury by restricting oxidative stress through the Akt\/Nrf2\/HO-1 signaling pathway. Environ Toxicol, 2022, 37: 858-867.","journal-title":"Environ Toxicol"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"12891","DOI":"10.1007\/s00210-025-04154-3","volume":"398","author":"Ahmed HS","year":"2025","unstructured":"Ahmed HS. Neuropharmacological effects of calycosin: a translational review of molecular mechanisms and therapeutic applications. Naunyn Schmiedebergs Arch Pharmacol, 2025, 398: 12891-12909.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.tins.2020.12.002","volume":"44","author":"Segarra M","year":"2021","unstructured":"Segarra M, Aburto MR, Acker-Palmer A. Blood-brain barrier dynamics to maintain brain homeostasis. Trends Neurosci, 2021, 44: 393-405.","journal-title":"Trends Neurosci"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","volume":"99","author":"Sweeney MD","year":"2019","unstructured":"Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV. Blood-brain barrier: from physiology to disease and back. Physiol Rev, 2019, 99: 21-78.","journal-title":"Physiol Rev"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.semcdb.2014.11.004","volume":"38","author":"Haseloff RF","year":"2015","unstructured":"Haseloff RF, Dithmer S, Winkler L, Wolburg H, Blasig IE. Transmembrane proteins of the tight junctions at the blood-brain barrier: structural and functional aspects. Semin Cell Dev Biol, 2015, 38: 16-25.","journal-title":"Semin Cell Dev Biol"},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/nyas.14798","volume":"1514","author":"Kuo W\u2010","year":"2022","unstructured":"Kuo W\u2010, Odenwald MA, Turner JR, Zuo L. Tight junction proteins occludin and ZO-1 as regulators of epithelial proliferation and survival. Ann N Y Acad Sci, 2022, 1514: 21-33.","journal-title":"Ann N Y Acad Sci"},{"key":"CITATION43","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"Wu D","year":"2023","unstructured":"Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. The blood-brain barrier: structure, regulation and drug delivery. Sig Transduct Target Ther, 2023, 8:","journal-title":"Sig Transduct Target Ther"},{"key":"CITATION44","doi-asserted-by":"publisher","first-page":"e20599","DOI":"10.1371\/journal.pone.0020599","volume":"6","author":"Feng S","year":"2011","unstructured":"Feng S, Cen J, Huang Y, Shen H, Yao L, Wang Y, Chen Z. Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins. PLoS One, 2011, 6:","journal-title":"PLoS One"},{"key":"CITATION45","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1161\/CIRCRESAHA.123.323371","volume":"134","author":"Arkelius K","year":"2024","unstructured":"Arkelius K, Wendt TS, Andersson H, Arnou A, Gottschalk M, Gonzales RJ, Ansar S. LOX-1 and MMP-9 inhibition attenuates the detrimental effects of delayed rt-PA therapy and improves outcomes after acute ischemic stroke. Circ Res, 2024, 134: 954-969.","journal-title":"Circ Res"},{"key":"CITATION46","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12987-024-00534-8","volume":"21","author":"Hladky SB","year":"2024","unstructured":"Hladky SB, Barrand MA. Alterations in brain fluid physiology during the early stages of development of ischaemic oedema. Fluids Barriers CNS, 2024, 21:","journal-title":"Fluids Barriers CNS"},{"key":"CITATION47","doi-asserted-by":"publisher","first-page":"111215","DOI":"10.1016\/j.intimp.2023.111215","volume":"126","author":"Zhu B","year":"2024","unstructured":"Zhu B, Cao A, Chen C, Zhou W, Luo W, Gui Y, Wang Q. MMP-9 inhibition alleviates postoperative cognitive dysfunction by improving glymphatic function via regulating AQP4 polarity. Int Immunopharmacol, 2024, 126:","journal-title":"Int Immunopharmacol"},{"key":"CITATION48","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s12975-023-01196-8","volume":"15","author":"Do PT","year":"2024","unstructured":"Do PT, Chuang DM, Wu CC, Huang CZ, Chen YH, Kang SJ, Chiang YH. Mesenchymal stem cells overexpressing FGF21 preserve blood-brain barrier integrity in experimental ischemic stroke. Transl Stroke Res, 2024, 15: 1165-1175.","journal-title":"Transl Stroke Res"},{"key":"CITATION49","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1038\/s41401-024-01323-7","volume":"45","author":"Zhang X","year":"2024","unstructured":"Zhang X, Du W, Qian S, Lu X, Yu X, Fang H, Dong J. Glial growth factor 2 treatment alleviates ischemia and reperfusion-damaged integrity of the blood-brain barrier through decreasing Mfsd2a\/caveolin-1-mediated transcellular and Pdlim5\/YAP\/TAZ-mediated paracellular permeability. Acta Pharmacol Sin, 2024, 45: 2241-2252.","journal-title":"Acta Pharmacol Sin"},{"key":"CITATION50","doi-asserted-by":"publisher","first-page":"10711","DOI":"10.2147\/JIR.S480262","volume":"17","author":"Yang X","year":"2024","unstructured":"Yang X, Pan Y, Cai L, Wang W, Zhai X, Zhang Y, Wu Q. Calycosin ameliorates neuroinflammation via TLR4-mediated signal following cerebral ischemia\/reperfusion injury in vivo and in vitro. J Inflamm Res, 2024, 17: 10711-10727.","journal-title":"J Inflamm Res"},{"key":"CITATION51","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s11481-019-09903-9","volume":"15","author":"Hsu CC","year":"2020","unstructured":"Hsu CC, Kuo TW, Liu WP, Chang CP, Lin HJ. Calycosin preserves BDNF\/TrkB signaling and reduces post-stroke neurological injury after cerebral ischemia by reducing accumulation of hypertrophic and TNF-\u03b1-containing microglia in rats. J Neuroimmune Pharmacol, 2020, 15: 326-339.","journal-title":"J Neuroimmune Pharmacol"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/5192B2A7B73D4CC2B87AD73E4440C150","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2025225","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/5192B2A7B73D4CC2B87AD73E4440C150","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:32:09Z","timestamp":1792578729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2025225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,4]]},"references-count":51,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,1,4]]},"published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.3724\/abbs.2025225","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,4]]}}}